KIT and melanoma: In contrast, expression of Shh pathway components (Gli-1, Gli-2, and Ptch-1) in the nevi from P4 and P5 and melanoma markers (c-kit, MAGE, and CDK4) in the nevus from P1 was markedly increased (Fig. 4A).